Cerebral vasculitis mimicking intracranial metastatic progression of lung cancer during PD-1 blockade
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cerebral vasculitis mimicking intracranial metastatic progression of lung cancer during PD-1 blockade
Authors
Keywords
Checkpoint inhibitor, Cancer immunotherapy, Autoimmune, Antibody, Brain metastasis
Journal
Journal for ImmunoTherapy of Cancer
Volume 5, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-05-25
DOI
10.1186/s40425-017-0249-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Irradiation and immunotherapy: From concept to the clinic
- (2016) April K. S. Salama et al. CANCER
- Eosinophilic Fasciitis and Acute Encephalopathy Toxicity from Pembrolizumab Treatment of a Patient with Metastatic Melanoma
- (2016) L. Khoja et al. Cancer Immunology Research
- Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
- (2015) Suzanne L. Topalian et al. CANCER CELL
- Immune-modulating properties of ionizing radiation: rationale for the treatment of cancer by combination radiotherapy and immune checkpoint inhibitors
- (2015) Anja Derer et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer
- (2015) Christina Twyman-Saint Victor et al. NATURE
- Nivolumab and Ipilimumab versus Ipilimumab in Untreated Melanoma
- (2015) Michael A. Postow et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer
- (2015) Julie Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer
- (2015) Hossein Borghaei et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma
- (2015) Robert J. Motzer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pembrolizumab versus Ipilimumab in Advanced Melanoma
- (2015) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
- (2015) James Larkin et al. NEW ENGLAND JOURNAL OF MEDICINE
- PD-1 Restrains Radiotherapy-Induced Abscopal Effect
- (2015) S. S. Park et al. Cancer Immunology Research
- Lambrolizumab induced central nervous system (CNS) toxicity
- (2014) Jacob J. Mandel et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Recent insights into the role of the PD-1/PD-L1 pathway in immunological tolerance and autoimmunity
- (2013) Elena Gianchecchi et al. AUTOIMMUNITY REVIEWS
- Analysis of 303 Ro/SS-A antibody-positive patients: is this antibody a possible marker for malignancy?
- (2012) B.C. Böckle et al. BRITISH JOURNAL OF DERMATOLOGY
- Human brain endothelial cells endeavor to immunoregulate CD8 T cells via PD-1 ligand expression in multiple sclerosis
- (2011) Camille L Pittet et al. Journal of Neuroinflammation
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now